Cargando…

Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

Detalles Bibliográficos
Autores principales: Zhang, Peitao, Guan, Haixia, Yuan, Shukai, Cheng, Huili, Zheng, Jian, Zhang, Zhenlei, Liu, Yifan, Yu, Yang, Meng, Zhaowei, Zheng, Xiangqian, Zhao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671907/
https://www.ncbi.nlm.nih.gov/pubmed/36396645
http://dx.doi.org/10.1038/s41467-022-34545-6
_version_ 1784832641532428288
author Zhang, Peitao
Guan, Haixia
Yuan, Shukai
Cheng, Huili
Zheng, Jian
Zhang, Zhenlei
Liu, Yifan
Yu, Yang
Meng, Zhaowei
Zheng, Xiangqian
Zhao, Li
author_facet Zhang, Peitao
Guan, Haixia
Yuan, Shukai
Cheng, Huili
Zheng, Jian
Zhang, Zhenlei
Liu, Yifan
Yu, Yang
Meng, Zhaowei
Zheng, Xiangqian
Zhao, Li
author_sort Zhang, Peitao
collection PubMed
description
format Online
Article
Text
id pubmed-9671907
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96719072022-11-19 Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors Zhang, Peitao Guan, Haixia Yuan, Shukai Cheng, Huili Zheng, Jian Zhang, Zhenlei Liu, Yifan Yu, Yang Meng, Zhaowei Zheng, Xiangqian Zhao, Li Nat Commun Author Correction Nature Publishing Group UK 2022-11-17 /pmc/articles/PMC9671907/ /pubmed/36396645 http://dx.doi.org/10.1038/s41467-022-34545-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Zhang, Peitao
Guan, Haixia
Yuan, Shukai
Cheng, Huili
Zheng, Jian
Zhang, Zhenlei
Liu, Yifan
Yu, Yang
Meng, Zhaowei
Zheng, Xiangqian
Zhao, Li
Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
title Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
title_full Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
title_fullStr Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
title_full_unstemmed Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
title_short Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
title_sort author correction: targeting myeloid derived suppressor cells reverts immune suppression and sensitizes braf-mutant papillary thyroid cancer to mapk inhibitors
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671907/
https://www.ncbi.nlm.nih.gov/pubmed/36396645
http://dx.doi.org/10.1038/s41467-022-34545-6
work_keys_str_mv AT zhangpeitao authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT guanhaixia authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT yuanshukai authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT chenghuili authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT zhengjian authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT zhangzhenlei authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT liuyifan authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT yuyang authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT mengzhaowei authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT zhengxiangqian authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors
AT zhaoli authorcorrectiontargetingmyeloidderivedsuppressorcellsrevertsimmunesuppressionandsensitizesbrafmutantpapillarythyroidcancertomapkinhibitors